Explore
Premium
Sign Up
Log In
Update to Valve Durability and Leaflet Thrombosis - Raj Makkar
↳ This is a section part of Moment:
CRT 2017 : FDA VALVE - Percutaenous Aortic Valves: Knowledge Gaps in a Maturing Technology
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Preview
Summary
Update to Valve Durability and Leaflet Thrombosis - Raj Makkar at CRT 2017.
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Target Audience
Learning Objectives
Other Components in this Moment
Overview
Beyond Strategy Trials: Are We Ready for OPCs? - Michael Reardon
Update to Valve Durability and Leaflet Thrombosis - Raj Makkar
Regulatory Pathways for New Indications - Jaime Raben
Extending the Boundaries of TAVR: Future Directions - Michael Mack
Loading Simple Education